Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma
Open Access
- 15 January 2012
- journal article
- Published by Taylor & Francis in Cell Cycle
- Vol. 11 (14) , 2729-2738
Abstract
MicroRNA (miRs) have emerged as salient regulators in cancer homeostasis and, recently, as putative therapeutics. Cholangiocarcinomas (CCA) are aggressive cancers with survival usually measured in months. mRNA arrays followed by pathway analysis revealed that miR-494 is a major modulator of the cell cycle progression from gap 2 (G₂) to mitosis (M). We performed fluorescence activated cell sorting (FACS) as well as differential interference contrast (DIC) microscopy, and confirmed that miR-494 induces a significant arrest in G₂/M in CCA cells. Furthermore, we verified that miR-494 modulates the protein level of six genes involved in the G₂/M transition: Polo-like Kinase 1 (PLK1), pituitary tumor-transforming gene 1 (PTTG1), Cyclin B1 (CCNB1), cell-division cycle 2 (CDC2), cell-division cycle 20 (CDC20) and topoisomerase II α (TOP2A). Next, we identified direct binding of miR-494 to the open reading frame (ORF) and downregulation of PTTG1 and TOP2A. In summary, our findings suggest that miR-494 has a global regulatory role in cell cycle progression, exerted by concerted effects on multiple proteins involved in gap 1 (G₁) to synthesis (S), as described previously, as well as G₂ to M progression. Therefore, it appears that the simultaneous effects of a single miR species on multiple targets along the same canonical pathway is advantageous for the usage of miRs as therapeutics. In addition, our data suggest that miRs act within a narrow range. miR expression above the upper threshold does not appear to induce further effects, which is reassuring in terms of off-target effects of miR surrounding noncancerous tissue.Keywords
This publication has 36 references indexed in Scilit:
- MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpointHepatology, 2011
- Inhibition of RhoA GTPase activity enhances hematopoietic stem and progenitor cell proliferation and engraftmentBlood, 2006
- Involvement of Human Micro-RNA in Growth and Response to Chemotherapy in Human Cholangiocarcinoma Cell LinesGastroenterology, 2006
- CholangiocarcinomaNature Clinical Practice Gastroenterology & Hepatology, 2006
- Targeted cancer therapyNature, 2004
- Identification of Novel Cellular Targets in Biliary Tract Cancers Using Global Gene Expression TechnologyThe American Journal of Pathology, 2003
- Influence of multiplicity of infection and protein stability on retroviral vector-mediated gene expression in hematopoietic cellsGene Therapy, 2001
- Discrimination of G2 and Mitotic Cells by Flow Cytometry Based on Different Expression of Cyclins A and B1Experimental Cell Research, 1995
- Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell linesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1994
- INTENSIVE COMBINATION CHEMOTHERAPY AND X-IRRADIATION IN HODGKINS DISEASE1967